FDA Pre-Submission Filed for Cardio inCode-SCORE_Commencement of regulatory pathway for US market approval
OXFORD, England, January 11, 2022 (Newswire.com) – GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of [...]